Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Debt Ratio: 2009-2025

Historic Debt Ratio for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to 0.12.

  • China Pharma Holdings' Debt Ratio fell 32.50% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year decrease of 15.79%. This contributed to the annual value of 0.17 for FY2024, which is 10.21% up from last year.
  • Latest data reveals that China Pharma Holdings reported Debt Ratio of 0.12 as of Q3 2025, which was down 37.54% from 0.20 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Debt Ratio high stood at 0.24 for Q3 2021, and its period low was 0.12 during Q3 2025.
  • Moreover, its 3-year median value for Debt Ratio was 0.17 (2024), whereas its average is 0.17.
  • In the last 5 years, China Pharma Holdings' Debt Ratio soared by 61.52% in 2021 and then crashed by 32.50% in 2025.
  • Over the past 5 years, China Pharma Holdings' Debt Ratio (Quarterly) stood at 0.19 in 2021, then dropped by 28.19% to 0.14 in 2022, then rose by 12.62% to 0.15 in 2023, then climbed by 10.21% to 0.17 in 2024, then slumped by 32.50% to 0.12 in 2025.
  • Its Debt Ratio was 0.12 in Q3 2025, compared to 0.20 in Q2 2025 and 0.18 in Q1 2025.